Aptimmune Named Number Three of Seven Ag Tech Start-ups to Watch in 2018

Categories : Features, Recognition & Awards
Posted on: January 30, 2018

EnterpriseWorks startup, Aptimmune Biologics, was recently recognized as one of seven Ag Tech start-ups to watch in 2018 by Agriculture.com. 

Aptimmune focuses on developing revolutionary swine vaccines and the prevention of the diseases, porcine reprodutive, respiratory syndrome virus ({PRRSV), and influenza. 

In November, Aptimmune launched the industry’s first inactivated mucosal influenza A virus vaccine in swine. 

Recently, the company raised $6 Million Series B Funding from various investors and has moved its headquarters to St. Louis. 

To see a complete list of Ag Tech startups to watch click here.

Visit Aptimmune’s website here.